New laser microscope could help surgeons save nerves during prostate cancer surgery

NCT ID NCT07541911

Recruiting now Diagnosis Sponsor: University College, London Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new microscope called LaserSAFE that scans the removed prostate during surgery to see if cancer cells are at the edge. If it works well, surgeons can decide right away whether to spare nearby nerves. About 693 men with prostate cancer will take part, and the study will check how accurate and fast the method is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LaserSAFE (confocal microscopy)
What this could lead to: If successful, LaserSAFE could give surgeons real-time information during prostate surgery to safely preserve nerves, improving recovery and quality of life for patients.
What could go wrong: This is a diagnostic test, not a treatment. It may not be accurate enough in practice, and the study is still recruiting. Results may not apply to all prostate cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma Margins of Excision prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATE CANCER (ADENOCARCINOMA)

Contacts and locations

Locations

University College London Hospital NHS Foundation Trust
RECRUITING

London, NW1 2BU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.